Feb 26, 2026 07:03AM
Feb 26, 2026 06:31AM
Feb 26, 2026 06:30AM
Oct 30, 2025 07:31AM
Oct 30, 2025 06:30AM
Aug 7, 2025 06:34AM
Aug 7, 2025 06:31AM Nuvalent begins NDA submission for cancer drug zidesamtinib
Aug 7, 2025 06:30AM
May 8, 2025 07:33AM
May 8, 2025 07:31AM
Feb 27, 2025 06:30AM
Nov 12, 2024 06:31AM
Nov 12, 2024 06:30AM
Aug 8, 2024 06:35AM Nuvalent, Inc. (NUVL) Misses Q2 EPS by 12c
Aug 8, 2024 06:30AM
May 9, 2024 06:34AM
May 9, 2024 06:31AM
May 9, 2024 06:30AM
Feb 28, 2024 07:30AM
Feb 27, 2024 06:32AM
Feb 27, 2024 06:30AM Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results
Nov 14, 2023 06:44AM
Nov 14, 2023 06:30AM
Aug 10, 2023 06:30AM
May 11, 2023 06:38AM
May 11, 2023 06:31AM
May 11, 2023 06:30AM
Mar 16, 2023 06:30AM Nuvalent Highlights Pipeline and Business Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
Nov 10, 2022 06:30AM
Aug 10, 2022 06:30AM
May 12, 2022 06:30AM
Mar 29, 2022 06:31AM
Mar 29, 2022 06:30AM
Nov 10, 2021 06:30AM
Sep 8, 2021 06:30AM Nuvalent Announces Business and Program Highlights and Reports Second Quarter 2021 Financial Results

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All